Such lysosomal impairment is a hallmark of GBA1-associated Parkinson’s disease and is also implicated in sporadic disease, where it drives oxidative stress, perturbs enzyme activity, and promotes α-synuclein aggregation [87,88]. The gene discussed is GBA1; the disease is Parkinson disease.